Cargando…

Adults With Mild‐to‐Moderate Congenital Heart Disease Demonstrate Measurable Neurocognitive Deficits

BACKGROUND: Neurocognitive impairment is a common complication of congenital heart disease (CHD) as well as acquired cardiovascular disease. Data are limited on neurocognitive function in adults with CHD (ACHD). METHODS AND RESULTS: A total of 1020 individuals with mild‐to‐moderate ACHD and 497 987...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrotta, Melissa L., Saha, Priyanka, Zawadzki, Roy, Beidelman, Mark, Ingelsson, Erik, Lui, George K., Priest, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792385/ https://www.ncbi.nlm.nih.gov/pubmed/32981450 http://dx.doi.org/10.1161/JAHA.119.015379

Ejemplares similares

Efficacy of PASS Reading Enhancement Programme on Neuropsychological Functions of a Child with Mild Vascular Neurocognitive Disorder and Comorbid Attention Deficit Hyperactivity Disorder: A Case Study
por: Chaudhury, Pourabi, et al.
Publicado: (2019)

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits
por: Perrotta, Gaetano, et al.
Publicado: (2017)

Frequent neurocognitive deficits after recovery from mild COVID-19
por: Woo, Marcel S, et al.
Publicado: (2020)

Transcranial pulse stimulation in the treatment of mild neurocognitive disorders
por: Fong, Tommy Kwan Hin, et al.
Publicado: (2023)

A phenome-wide association study of 26 mendelian genes reveals phenotypic expressivity of common and rare variants within the general population
por: Tcheandjieu, Catherine, et al.
Publicado: (2020)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

Awareness of memory deficits is useful to distinguish between depression and mild cognitive impairment in the elderly
por: Coutinho, Gabriel, et al.
Publicado: (2016)

Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay
por: Cammisuli, Davide Maria, et al.
Publicado: (2021)

Malaria Related Neurocognitive Deficits and Behavioral Alterations
por: Rosa-Gonçalves, Pamela, et al.
Publicado: (2022)

Congenital heart disease and risk of severe COVID
por: Lim, Gregory B.
Publicado: (2021)

When ‘mild’ COVID-19 is not so mild
por: Minton, Kirsty
Publicado: (2022)

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Anatomical and Functional Deficits in Patients with Amnestic Mild Cognitive Impairment
por: Han, Ying, et al.
Publicado: (2012)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

Adenotonsillectomy and Neurocognitive Deficits in Children with Sleep Disordered Breathing
por: Kohler, Mark J., et al.
Publicado: (2009)

Neurocognitive psychotherapy for adult attention deficit hyperactive disorder
por: Halder, Susmita, et al.
Publicado: (2009)

Theta oscillations in prolactinomas: Neurocognitive deficits in executive controls
por: Cao, Chenglong, et al.
Publicado: (2020)

Correlation of neurocognitive deficits with positive and negative symptoms in schizophrenia
por: Priyamvada, Richa, et al.
Publicado: (2021)

Neurocognitive deficits in HIV/AIDS patients on HAART Regime
por: Kumar, Kalagi Amit
Publicado: (2022)

Neurocognitive deficits in survivors of childhood acute myeloid leukemia
por: Takahashi, Satoko, et al.
Publicado: (2022)

Immune checkpoint inhibitor induced neurocognitive deficits in patients
por: Zeiser, Robert, et al.
Publicado: (2023)

Can theory of mind deficits be measured reliably in people with mild and moderate Alzheimer’s dementia?
por: Choong, Caroline SM, et al.
Publicado: (2013)

Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant
por: Balaraju, Sunitha, et al.
Publicado: (2019)

Effect of Atomoxetine on the Cognitive Functions in Treatment of Attention Deficit Hyperactivity Disorder in Children with Congenital Hypothyroidism: A Pilot Study
por: Yang, Rongwang, et al.
Publicado: (2015)

Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease
por: Lucza, Tivadar, et al.
Publicado: (2015)

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience
por: Amanam, Idoroenyi, et al.
Publicado: (2023)

A study on association of iron deficiency with attention deficit hyperactivity disorder in a tertiary care center
por: Islam, Kamirul, et al.
Publicado: (2018)

Clinical predictors of neurocognitive deficits in children with chronic kidney disease
por: Slickers, Jennifer, et al.
Publicado: (2007)

Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
por: Weickert, Thomas W., et al.
Publicado: (2016)

Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments
por: Martínez, Antígona, et al.
Publicado: (2015)

Neurocognitive Deficits Associated With ADHD in Athletes: A Systematic Review
por: Poysophon, Poyrung, et al.
Publicado: (2018)

Neurocognitive deficits in obsessive–compulsive disorder: A selective review
por: Suhas, Satish, et al.
Publicado: (2019)

A case of neurocognitive deficit strongly related to dasatinib therapy
por: Chamoun, Kamal, et al.
Publicado: (2020)

Relationship between cognitive functions and empathy in patients with neurocognitive deficit
por: Galletta, D., et al.
Publicado: (2021)

Neurocognitive functioning in individuals with congenital central hypoventilation syndrome
por: Macdonald, Kelly T., et al.
Publicado: (2020)

Individuals with mild-to-moderate hip osteoarthritis have lower limb muscle strength and volume deficits
por: Loureiro, Aderson, et al.
Publicado: (2018)

Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables
por: Yu, Miao, et al.
Publicado: (2015)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

State-Based and Demographic Variation in Parent-Reported Medication Rates for Attention-Deficit/Hyperactivity Disorder, 2007–2008
por: Visser, Susanna N., et al.
Publicado: (2013)

Cortical Neuroplasticity and Cognitive Function in Early-Stage, Mild-Moderate Hearing Loss: Evidence of Neurocognitive Benefit From Hearing Aid Use
por: Glick, Hannah Anneli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iut3e6knfsv00sescvm0jmrfnb